Use Of Chemometrics For Development And Validation Of RP-HPLC Method For Simultaneous Determination Of Dimenhydrinate And Cinnarizine

被引:0
作者
Jayaseelan, Subramanian [1 ]
Kannappan, Nagappan [2 ]
Ganesan, Vellichamy [3 ]
机构
[1] Erode Coll Pharm, Dept Pharmaceut Anal, Erode, Tamil Nadu, India
[2] Annamalai Univ, Dept Pharm, Chidambram, Tamil Nadu, India
[3] Erode Coll Pharm, Dept Pharmaceut, Erode, Tamil Nadu, India
来源
INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH | 2022年 / 12卷 / 01期
关键词
Central Composite Design; Optimum Conditions; RP-HPLC; Dimenhydrinate; Cinnarizine and tablet dosage form; DOSAGE FORM; DIPHENHYDRAMINE HYDROCHLORIDE; OPTIMIZATION; MALEATE;
D O I
10.22376/ijpbs/lpr.2022.12.1.L67-78
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel simple, sensitive, rapid and accurate isocratic RP-HPLC method was developed and validated for simultaneous determination of Dimenhydrinate and Cinnarizine applying statistical experimental design. Design of experiments (DoE) was applied for multivariate optimization of the experimental conditions of the RP-HPLC method. Three independent factors like; mobile phase composition, phosphate buffer strength and flow rate were employed to design mathematical models. Central composite design (CCD) was applied to study the response surface methodology. This study was used to find the deepness effects of these independent factors. Desirability function was used to simultaneously optimize the retention time and resolution of the analytes. Hence, our present study was aimed in finding the optimized and predicted data from the contour diagram. Mobile phase consisted of acetonitrile and ammonium acetate buffer (pH 7.0, strength 0.3 mM) in the ratio of 55:45%v/v respectively, at a flow rate of 1.7 mL/min was used. The present study objectives were to apply these optimum conditions baseline partition of both drugs with good resolution. The run time of less than 12.0 min was accomplished. The optimized assay conditions were validated according to ICH guidelines. The correlation coefficient value was found to be r(2) = 0.9990 and 0.9993 for Dimenhydrinate and Cinnarizine respectively. LOD and LOQ value was found to be least concentration for both drugs. It indicates the method was highly sensitive. The accuracy %RSD value was found to be less than 2%. Consequently the reports clearly showed that Quality by design approach could be triumphantly applied to optimize RP-HPLC method for simultaneous determination of Dimenhydrinate and Cinnarizine.
引用
收藏
页码:67 / 78
页数:12
相关论文
共 29 条
[1]  
Ahmed A.B., 2017, B FACULTY PHARM CAIR, V55, P163, DOI [10.1016/j.bfopcu.2017.01.003, DOI 10.1016/J.BFOPCU.2017.01.003]
[2]   Visible Spectrophotometric Determination of Chlorpheniramine Maleate and Diphenhydramine Hydrochloride in Raw and Dosage form Using Potassium Permanganate [J].
Al Bratty, Mohammed .
ORIENTAL JOURNAL OF CHEMISTRY, 2016, 32 (02) :885-894
[3]  
[Anonymous], 2010, BRIT PHARMACOPOEIA, P507
[4]  
[Anonymous], INT C HARMONIZATION, P1
[5]   Simultaneous determination of cinnarizine and domepiridone maleate from tablet dosage form by reverse phase ion pair high performance liquid chromatography [J].
Argekar, AP ;
Shah, SJ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 19 (06) :813-817
[6]   Statistical media optimization and alkaline protease production from Bacillus mojavensis in a bioreactor [J].
Beg, QK ;
Sahai, V ;
Gupta, R .
PROCESS BIOCHEMISTRY, 2003, 39 (02) :203-209
[7]  
Chauhan Ruchita J., 2014, PHARMA SCI MONITOR, V5, P267
[8]  
DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968
[9]   A simple HPLC-UV method for the determination of dimenhydrinate and related substances -: identification of an unknown impurity [J].
Doege, U. ;
Eger, K. .
PHARMAZIE, 2007, 62 (03) :174-178
[10]   Experimentally designed chromatographic method for the simultaneous analysis of dimenhydrinate, cinnarizine and their toxic impurities [J].
Edrees, Fadwa H. ;
Saad, Ahmed S. ;
Alsaadi, Mohammed T. ;
Amin, Noha H. ;
Abdelwahab, Nada S. .
RSC ADVANCES, 2021, 11 (03) :1450-1460